Celldex Therapeutics (CLDX) EBIT (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly EBIT came in at -$84.4 million in Q1 2026, down 34.58% year-on-year from -$129.1 million in Q1 2025, and up 3.12% quarter-over-quarter from -$87.2 million in Q4 2025.
Celldex Therapeutics (CLDX) EBIT (2010 - 2026) Analysis & Trends
Celldex Therapeutics' EBIT history runs 17 years deep, the most recent figure standing at -$84.4 million for Q1 2026.
- On a quarterly basis, EBIT fell 34.58% year-over-year to -$84.4 million in Q1 2026; TTM through Mar 2026 was -$309.1 million, a 42.29% decrease from a year earlier, with the FY2025 full-year figure at -$287.4 million, down 47.31% from the prior year.
- EBIT improved to -$84.4 million in Q1 2026 per CLDX's latest filing, from -$87.2 million in the prior quarter.
- Across five years, EBIT topped out at -$23.3 million in Q1 2022 and bottomed at -$87.2 million in Q4 2025.
- The 5-year median for EBIT is -$46.3 million (2024), against an average of -$49.2 million.
- Across the five-year window, EBIT tumbled 170.8% in 2022 and rose 8.77% in 2023, its largest moves.
- Year by year, EBIT stood at -$27.9 million in 2022, then plunged by 70.8% to -$47.6 million in 2023, then decreased by 17.64% to -$56.0 million in 2024, then sank by 55.56% to -$87.2 million in 2025, then gained by 3.12% to -$84.4 million in 2026.
- Per Business Quant, the three latest CLDX EBIT figures stand at -$84.4 million (Q1 2026), -$87.2 million (Q4 2025), and -$73.6 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | -84.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.44 Mn |
| Dec 31, 2025 | -87.15 Mn |
| Sep 30, 2025 | -73.62 Mn |
| Jun 30, 2025 | -63.86 Mn |
| Mar 31, 2025 | -62.74 Mn |
| Dec 31, 2024 | -56.03 Mn |
| Sep 30, 2024 | -52.13 Mn |
| Jun 30, 2024 | -46.32 Mn |
| Mar 31, 2024 | -40.61 Mn |
| Dec 31, 2023 | -47.63 Mn |
| Sep 30, 2023 | -41.24 Mn |
| Jun 30, 2023 | -33.21 Mn |
| Mar 31, 2023 | -32.47 Mn |
| Dec 31, 2022 | -27.89 Mn |
| Sep 30, 2022 | -27.70 Mn |
| Jun 30, 2022 | -36.40 Mn |
| Mar 31, 2022 | -23.26 Mn |
| Dec 31, 2021 | -20.34 Mn |
| Sep 30, 2021 | -20.82 Mn |
| Jun 30, 2021 | -13.44 Mn |